Document is current
Any future updates will be listed below
-
Authors
Kennedy, Beatrice
Fitipaldi, Hugo https://orcid.org/0000-0001-5352-2134
Hammar, Ulf
Maziarz, Marlena https://orcid.org/0000-0003-1417-6050
Tsereteli, Neli
Oskolkov, Nikolay
Varotsis, Georgios
Franks, Camilla A.
Nguyen, Diem https://orcid.org/0000-0002-9680-5772
Spiliopoulos, Lampros
Adami, Hans-Olov https://orcid.org/0000-0001-9592-5791
Björk, Jonas https://orcid.org/0000-0003-1883-2000
Engblom, Stefan https://orcid.org/0000-0002-3614-1732
Fall, Katja
Grimby-Ekman, Anna
Litton, Jan-Eric
Martinell, Mats
Oudin, Anna
Sjöström, Torbjörn
Timpka, Toomas https://orcid.org/0000-0001-6049-5402
Sudre, Carole H.
Graham, Mark S.
du Cadet, Julien Lavigne
Chan, Andrew T.
Davies, Richard https://orcid.org/0000-0003-2050-3994
Ganesh, Sajaysurya
May, Anna
Ourselin, Sébastien
Pujol, Joan Capdevila
Selvachandran, Somesh
Wolf, Jonathan https://orcid.org/0000-0002-0530-2257
Spector, Tim D. https://orcid.org/0000-0002-9795-0365
Steves, Claire J. https://orcid.org/0000-0002-4910-0489
Gomez, Maria F. https://orcid.org/0000-0001-6210-3142
Franks, Paul W. https://orcid.org/0000-0002-0520-7604
Fall, Tove https://orcid.org/0000-0003-2071-5866
- License Information
-
More Information
Article History
Received: 20 August 2021
Accepted: 24 March 2022
First Online: 21 April 2022
Competing interests
: CSSS is a strictly non-commercial research project. P.F. consults for and has stock options in ZOE Limited relating to the PREDICT nutrition studies, which are entirely separate from the COVID Symptom Study app development and COVID-19 research. A.T.C. previously served as an investigator on the PREDICT nutrition studies. T.D.S. is a consultant to ZOE Limited. T.S. is the current CEO and a shareholder at Novus International Group AB, Sweden. R.D., J.W., J.C.P., S.G., A.M., S.S. and J.L.C. work for ZOE Limited. All other authors declare that they have no competing interests.
